Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

MENU

Cell Lines

Technology Transfer Contacts
(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11
 
TECH ID   TITLE  LEAD INVENTOR   CONTACT  

 01-04

FC-muMCL1 murine mantle cell lymphoma model cell line

Abstract

 Mitchell Smith

Tatiana Venkova

 01-21

 N38-2C12/Va14+ T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 01-22

 

 N38-2C12/ Bv8.2 T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 03-21

OVCAR-3 ovarian carcinoma cell line from a patient refractory to cisplatin

Abstract

Thomas Hamilton

Tatiana Venkova

 03-22

OVCAR-4 ovarian carcinoma cell line from a patient refractory to cisplatin

Abstract

Thomas Hamilton

Tatiana Venkova

 03-23

OVCAR-5 ovarian carcinoma cell line from untreated advanced tumor

Abstract

Thomas Hamilton

Tatiana Venkova

 03-26

A2780 ovarian cancer cell line (cisplatin sensitive) derived from patient prior to treatment

 

 Thomas Hamilton 

Tatiana Venkova

 03-32R

MOVCAR cell lines

Abstract

 Denise Connolly

Natalia Shalginskikh

 04-30

A2780/CP70 and CP30 cisplatin-resistant cell lines

Abstract

Thomas Hamilton 

Tatiana Venkova

 05-18

 Mesothelioma cell lines

Abstract

 Joseph Testa

Tatiana Venkova

07-14

PE01 human ovarian cancer cell line

 

Thomas Hamilton 

Tatiana Venkova

 07-28

 N38-3C3 NK T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 95-13

 HepAD38: tet-inducible HBV expression cell line 

Abstract

 Christoph Seeger

Natalia Shalginskikh

 99-31

 HepG2.2.15 cell line

Abstract

 Marianne Sells

Tatiana Venkova

 120-RK

 Inducible HeLa TI-C GFP cells

Abstract

 Richard Katz

Natalia Shalginskikh

 133-JR

bsMCF: triple-negative breast cancer, Boyden chamber-selected tumorigenic cells

Abstract

 Jose Russo

Natalia Shalginskikh

 134-JR

trMCF: triple-negative breast cancer, estradiol-transformed cells

Abstract

 Jose Russo

Natalia Shalginskikh

 150-WM

 LMH-D2 duck hepatitis B virus-expressing cell line

 

 William Mason 

Tatiana Venkova

 156-KH

N37-1A12 T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 191-CS

Dstet5 cells

Abstract

 Christoph Seeger

Natalia Shalginskikh

 249-JT

Murine Thymic Lymphoma cells from Lck-Akt2 mice

Abstract

 Joseph Testa

Tatiana Venkova

 263-DB

Liposarcoma cell line  LS2

 

 Margaret von Mehren

Natalia Shalginskikh

 272-JT

APPL1KO/WT MEF (murine embryonic fibroblasts)

Abstract

 Joseph Testa

Natalia Shalginskikh

 295-CS

HeLa HCV replicon 

Abstract

 Christoph Seeger

Natalia Shalginskikh

310-MC

Inflammatory breast cancer cell line FC-IBC02

Abstract

Massimo Cristofanilli 

Tatiana Venkova

 344-JR

T4 cell line

 

 Jose Russo

Natalia Shalginskikh

 353-DW

Scid.adh: a thymic cell line that mimics T-cell development invitro

Abstract

 David Wiest

Natalia Shalginskikh

 379-CS

NTCP-HepG2 cell line

Abstract

 Christoph Seeger

Natalia Shalginskikh

 382-CS

NTCP-Cas9-HepG2 cell line

 

 Christoph Seeger

Natalia Shalginskikh

 384-CS

Hep AD38-Cas9 cell line

 

 Christoph Seeger

Natalia Shalginskikh

 451-HB

HEK293-MRP3 cells

 

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 452-HB

HEK293-pcDNA Vector control cell line for MRP cells

 

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 453-HB

HEK293-MRP7-C17 cells 

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 454-HB

MEF 405 (MRP -/-, Pgp -/-) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 455-HB

MEF 205 (MRP +/+, Pgp -/-) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 456-HB

HEK293-MRP7-C18 cells 

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 457-HB

MEF 237 (MRP -/-, Pgp +/+) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

535-HB

Wild type (WT) mouse embryonic fibroblasts (MEFs): control for 454-HB;455-HB and 457-HB

Abstract

Elizabeth Hopper-Borge

Natalia Shalginskikh

 458-JR

LmMCF cell line: triple-negative breast cancer cells derived from lung metastasis of bsMCF cells

Abstract

 Jose Russo

Natalia Shalginskikh

 459-JR

XtMCF cell line:  triple-negative breast cancer cells derived from xenograft of bsMCF cells

Abstract

 Jose Russo

Natalia Shalginskikh

 468-SA

EBV-B cell line from a patient with renal cancer carrying mutation in the intronic region of RRM2B gene 

Sanjeevani Arora

Tatiana Venkova

 478-LW 

B16BL6-D5-HER2 cell line

Abstract

 Louis Weiner

Natalia Shalginskikh

503-MC

EMF-011 cell line from patient with inflammatory breast cancer

Abstract

Massimo Cristofanilli

Tatiana Venkova

504-AKS

BEAS-2B-CSC 1196 xenograft-derived human bronchial epithelial cells (non-tumor derived)

Abstract

Andres Klein-Szanto

Tatiana Venkova

505-AKS

BEAS-2B-BW 1799 xenograft-derived human bronchial epithelial cells (control)

Abstract

Andres Klein-Szanto

Tatiana Venkova

506-AKS

 BEAS-2B-CSC 1198 xenograft-derived human bronchial epithelial cells (non-tumor derived)

Abstract

Andres Klein-Szanto

Tatiana Venkova

507-AKS

BEAS-2B-CSC 1170-I xenograft-derived human bronchial epithelial cells (tumor derived)

Abstract

Andres Klein-Szanto

Tatiana Venkova

525-EC

Immortalized human pancreatic cancer-associated fibroblasts engineered to limit alpha 5 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

526-EC

Immortalized human pancreatic cancer-associated fibroblasts engineered to limit αV integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

527-EC

Immortalized human pancreatic cancer-associated fibroblasts engineered to limit β3 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

528-EC

Immortalized human pancreatic cancer-associated fibroblasts engineered to limit β5 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

529-EC

Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit α5 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

530-EC

Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit αV integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

531-EC

Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit β3 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

532-EC

Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit β5 integrin expression

Abstract

Edna Cukierman

Natalia Shalginskikh

537-DC

MOVCAR cell lines

Abstract 1; Abstract 2

Denise Connolly

Natalia Shalginskikh

540-KC

SKOV3 cells expressing high levels of SLAMF7 

Abstract 1; Abstract 2

Kerry Campbell

Natalia Shalginskikh

556-IA

KPC3 murine PDAC cell lines  

Abstract

Igor Astsaturov

Natalia Shalginskikh

557-IA

KPC4b murine PDAC cell lines 

Abstract

Igor Astsaturov

Natalia Shalginskikh

 

Connect with Fox Chase